Autologous Serum Obtained by a Closed-Circuit Collection Device

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 20, 2026

Study Completion Date

June 20, 2027

Conditions
GVHDMeibomian Gland Dysfunction (Disorder)Stevens-Johnson SyndromeLimbal KeratoconjunctivitisRecurrent Erosions of Persistent Epithelial DefectsNeurotrophic UlcerSjogren Syndrome With Keratoconjunctivitis
Interventions
DRUG

Autologous Serum 20%

The collection of autologous serum in a closed blood processing system for ocular use

Trial Locations (1)

05410020

HCFMUSP, São Paulo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

JP Farma

UNKNOWN

lead

GIANCARLO FATOBENE

OTHER